Leading players include Novo Nordisk, Eli Lilly, Merck & Co., Sanofi, AstraZeneca, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim, Novartis, Johnson & Johnson, Bayer, Pfizer, and Janssen Pharmaceuticals
Most insurance policies do not cover Vitamin IV therapy, as it is often classified as an elective or wellness treatment rather than a medical necessity
Tailoring these treatments to individual patient profiles can enhance their efficacy in preventing disease progression
Apart from the advantageous effect, delivery of miRNA to the targeted site suffers from several drawbacks like high toxicity, failure to transport enough miRNAs to the target tissues, and lack of targeting and stability in cellular environment [110]